SciDev.Net reports on two recent studies published in the Canadian Medical Association Journal which look at how frequently health care providers and researchers in developing countries access research-based evidence. The studies “[t]he researchers, who examined research and practice in four areas at the heart of the U.N. Millennium Development Goals [MDGs], surveyed 1,500 healthcare providers and just over 300 researchers in 10 [low- and middle-income countries] â€“ China, Ghana, India, Iran, Kazakhstan, Laos, Mexico, Pakistan, Senegal and Tanzania,” the news service writes.
Giving women vitamin A supplements does not reduce maternal death rates or improve the health of infants, according to a study published Tuesday in the Lancet, the New York Times reports.
Also In Global Health News: Syphilis In China; HIV Vaccine Development; Tracking Malaria Outbreaks; Ecuador’s Maternity Law
Journal Perspective Piece DiscussesÂ Rising Number Of Syphilis Cases In China In 2008, almost 9,500 babies were born with syphilis in China, “a 12-fold increase over a five year period,”Â according to a New England Journal of Medicine perspective piece,Â theÂ “China Real Time Report” blog reports, addingÂ that the resurgence of the disease is…
Adopt Draft Code Of Health Personnel Recruitment At WHA, Lancet Comment Says As the 193 WHO member states gather at next week’s World Health Assembly (WHA) “a draft global code of practice on the international recruitment of health personnel will be on the agenda. Negotiation and adoption of a WHO…
CBSNews.com reports on the development of a dry, inhalable measles vaccine by researchers at the University of Colorado-Boulder (CU-Boulder), who hope that their work will “help pave the way for the inexpensive treatment of a range of other illnesses” (Cooper, 5/5).
Lancet Examines WHO’s Policy Reversal On Drug Used To Prevent Post-Partum Hemorrhage A Lancet Comment reflects on a debate over the community-based use of the drug misoprostol in resource poor settings to help reduce post-partum hemorrhage, which according to the commentÂ is the most common cause of maternal deaths. Despite evidence…
“Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it â€“ by infusing the medicine into vaginal gels and contraceptive-style rings,” the Associated Press reports in a piece that examines researchers’ latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Also In Global Health News: HIV/AIDS Prevention For Drug Users; Obstetric Fistulas; Ugandan Health Spending
U.S., Tanzanian Leaders Launch Program Aimed At Reducing Spread Of HIV/AIDS Among Drug Users The U.S. together with the Tanzanian government on Monday unveiled a plan for “the first Medication Assisted Therapy (MAT) programme for drug users in sub-Saharan Africa, a crucial part of HIV control that allows addicts to…
PlusNews/IRIN examines what the global adult mortality data, released Friday in the journal Lancet, suggests about HIV/AIDS. According to the news service, the study, based on an analysis of adult mortality rates between 1970 and 2010 in 187 countries, revealed: “HIV was key to reversing the worldwide decline in mortality from 1970 to 1990. Even though worldwide mortality is still about 26 percent lower than it was 40 years ago, there are regional imbalances. In sub-Saharan Africa, hard hit by HIV, mortality is at levels not seen in developed countries such as Sweden since the 1700s.”
Study Finds Pfizer’s Pneumonia, Meningitis Vaccine Protects Against Recurrent Pneumonia In HIV Patients
Pfizer’s Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawai, according to a study published Thursday in the New England Journal of Medicine, Reuters reports.